CBD Oil News Roundup April 17th 2018

Texas poised to ban products with CBD oil (kten.com)

Topics: opioid, side effects, chronic pain, older people, PTSD, Texas, natural remedies, common misconceptions

The Texas Cannabis Industry Association refers to the state’s proposal as “another blow to Texans that rely on natural remedies,” and said it would be “detrimental to thousands of Texans.”

The Texas Department of State Health Services is taking public comments until Monday; you can view the proposed rules below.

“My doctor sends people here that have chronic pain, because we all know about the opioid crisis, and everybody’s getting hooked on that,” he said.

Despite stigma about cannabis, CBD oil takes off in Charleston (abcnews4.com)

Topics: special needs, grocery store, South Carolina, pilot program, California, big box stores, Harper, Mount Pleasant

During those five years, it was simply sensory overload, from the music to the humming fluorescent lights to the large spaces and now she goes every Saturday and loves Trader Joe’s.”

It was a welcomed alternative after years of taking pharmaceutical drugs with little to no impact, but a long list of side effects, she said.

“Once I discovered that CBD would help my little girl, I started looking for better products because there’s a lot of mislabeling, it’s very confusing.”

Cannabis Compound CBD May Offer Medical Marijuana Benefits Without The High (newyork.cbslocal.com)

Topics: Medical marijuana, chronic pain, Connecticut, NEW YORK, side effects, healthy diet, New Jersey, skin conditions

But the compound cannabidol, or CBD oil, falls into a gray area that might be legal in other states, because it’s not psychoactive – which may explain its expanding use.

There are limited studies suggesting CBD may help with epilepsy, chronic pain, anxiety disorders, insomnia, acne, diabetes and Alzheimer’s disease.

“They’ll use it for skin conditions from eczema to psoriasis to sunburn,” Cindy Capobianco, of Lord Jones products, said.

What Is CBD Oil—and Will It Really Relieve Your Chronic Pain and Sleep Problems? (prevention.com)

Topics: Tennessee, North Carolina, Alabama, Missouri, Oklahoma, Kentucky, Iowa, Mississippi

Seventeen additional states have CBD-specific laws on the books: Alabama, Georgia, Indiana, Iowa, Kentucky, Mississippi, Missouri, North Carolina, Oklahoma, South Carolina, South Dakota, Tennessee, Texas, Utah, Virginia, Wisconsin, and Wyoming.

In the United States, cannabidiol is classified as a Schedule 1 drug (with no currently accepted medical use and a high potential for abuse), so the government requires extensive documentation from researchers interested in studying it and subjects them to extensive regulations.

The FDA is reviewing a New Drug Application (NDA) for Epidiolex, a pharmaceutical-grade CBD product used in the treatment of seizures associated with Lennox-Gastaut syndrome and Dravet syndrome, two rare conditions of childhood-onset epilepsy.

Drug Made From Cannabis Plant Gets Backing From FDA Staff (bloomberg.com)

Topics: Food and Drug Administration, medical marijuana, National Institutes of Health, drug company, liver injury, synthetic cannabinoids, cannabidiol, increased risk

Insys is developing a cannabidiol oral solution for a severe type of epileptic seizure known as infantile spasms, and childhood epilepsy defined by staring spells where the child isn’t aware or responsive.

The drug company is seeking to sell the oral solution to treat seizures associated with two forms of epilepsy, Lennox-Gastaut and Dravet syndromes, in patients aged 2 or older.

The treatment, which GW Pharma hopes to market under the name Epidiolex, is produced in the U.K. from a plant that has been bred to have a high cannabidiol, or CBD, content, chief executive officer Justin gover said in an interview earlier this month.

Leave a Reply

Your email address will not be published. Required fields are marked *